Standard BioTools Inc.: revenue
| Value | {"amount": 91008000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | Standard BioTools Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:38:54.584182+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d5d1267f-323b-4dbc-afc6-9ad8a9abdc32
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-26-108326Retrieved: 2026-08-19T11:38:54.584182+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001162194/revenue/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d5d1267f-323b-4dbc-afc6-9ad8a9abdc32
History
- supersedes {"amount": 174432000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0000950170-25-036608)